A Study to Evaluate the Safety, Tolerability, and Blood Levels of PF-03654746 in Subjects With Mild to Moderate Alzheimer's Disease

Summary

This is a study to evaluate the safety, tolerability and blood levels of PF-03654746 in subjects will mild to moderate Alzheimer's disease.

Timeline

Start

2009-12

Primary completion

2010-05

Completion

2010-05

Outcome

Outcome not reported

Stopped (Enrollment): “This study terminated 27Apr2010 due to slow recruitment and the need to use the existing information to determine dosing for another study.”

Drugs

Indications